Tumor-marker monitoring is potentially a powerful tool to accomplish these goals. For follicular cell-derived thyroid carcinoma (excluding anaplastic cancer), which accounts for approximately 97% ...

Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb.

Additionally, researchers have identified specific genetic markers that may help predict thyroid cancer risk in certain populations. Leading endocrinologists and primary care physicians emphasize ...

Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...

Additionally, blood tests that measure thyroid hormone levels and tumor markers may be performed to monitor for disease progression. Treatment options for metastatic thyroid cancer after ...

Papillary and follicular thyroid cancers are considered well-differentiated cancers. Papillary thyroid cancer is the most prevalent type of thyroid cancer--with over 50,000 new cases per year in the ...

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

Thyroid cancer recurrence risk was not elevated among patients with high-normal vs low-normal exposure to TSH following thyroidectomy.

Head and neck, surgical, radiation, and medical oncologists in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center specialize in the diagnosis and treatment of thyroid cancer ...

HealthDay News — The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, ...

Thyroid cancer patients require close monitoring even after treatment, as recurrence is possible. Follow-up care usually includes regular physical exams, blood tests for thyroglobulin (a marker ...

In summary, Tg is a well-established thyroid cancer tumor marker. Its limitations center on TgAb interferences, which affect a significant subset of patients and on the fact that it is thyroid ...